Echo Therapeutics Inc (NASDAQ:ECTE)

2.33
Delayed Data
As of 9:57am ET
 -0.0799 / -3.32%
Today’s Change
0.39
Today|||52-Week Range
3.68
+72.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues428.5K447.2K5.1K27.6K
 
 
 
 
 
Depreciation And Amortization109.4K47.9K145.2K391.6K
 
 
 
 
 
 
Operating ExpensesGross Income319.0K------
 
 
General Expenses5.2M8.7M14.9M19.3M
 
 
 
 
 
Research And Development2.6M3.8M8.7M11.3M
 
 
 
 
 
Total Operating Expenses5.3M8.7M15.0M19.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.9M-8.3M-15.0M-19.6M
 
 
 
 
 
Extraordinary Credit555.2K0.003.7M4.5M
 
 
 
 
Extraordinary Charge0.00-1.8M0.000.00
 
 
Interest Expense On Debt37.5K13.9K959.9K3.9M
 
 
 
 
 
Other Expenses244.5K-1.3K-21.3K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.1M-10.0M-12.3M-19.1M
 
 
 
 
 
Preferred Dividend-131.7K-6.7M0.00-371.1K
 
 
 
 
Net Income-4.1M-10.0M-12.3M-19.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.9M3.4M4.0M8.4M
 
 
 
 
 
Shares To Calculate EPS Diluted2.9M3.4M4.0M8.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.50-$4.90-$3.10-$2.33
 
 
 
 
 
EPS Diluted-$1.50-$4.90-$3.10-$2.33
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account